AzTrials
AzTrials

StrokeNCT05479903

Study on the Correlation Between Neurotrophic Factors and the Condition of Stroke Patients

A study testing acupuncture, computerized cognitive training system and aerobic exercise in people with Stroke, run by Chongqing Medical University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Stroke is currently the most common disabling disease, which often leads to impairment of sensory, motor, speech and psychological functions, resulting in a reduced quality of life for patients. Read more about this study

Who is it for?
Ages 18 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Stroke
What is being tested?
acupuncture, computerized cognitive training system and aerobic exercise
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
300 participants
Where
1 siteChina
Study dates
16 Nov 2021to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Symptom recognition to admission ≤ 72 hours
  • Clear imaging evidence
  • Diagnosis of spontaneous cerebral hemorrhage by an immobilized physician according to relevant guidelines; pre-onset mRS score ≤ 1

Who cannot join

  • This onset was caused by traumatic and violent factors
  • History of previous intracranial surgery
  • Previous cerebrovascular accident
  • Previous speech disorders and limb movement disorders
  • Participation in other trials in the last three months.

Trial locations and contacts

1 site in 1 country.

Lingcong Li, M.S. in Medicine contact

+8602385381636

molly2816@163.com

China1 site, 1 recruiting
  • Yongchuan Hospital of Chongqing Medical University

    Chongqing

    Lingcong Li, M.S. in Medicine, +8602385381636, molly2816@163.com

    Recruiting

Other trials in China

About this study

Official title: Clinical Study of the Relationship Between Different Interventions for Post-stroke Functional Impairment and Neurotrophic Factors

Stroke is currently the most common disabling disease, which often leads to impairment of sensory, motor, speech and psychological functions, resulting in a reduced quality of life for patients. Therefore, post-stroke functional rehabilitation, especially the rehabilitation of physical function and psychological condition, is particularly important for patients to rejoin society. Acupuncture can promote the functional recovery of patients and facilitate the rehabilitation of limb function, thus improving the quality of survival of post-stroke patients.

Neurotrophic factors are diverse, most of which are mainly derived from neuronal cells in the central nervous system and are involved in a variety of neurological functions such as cell growth, differentiation and plasticity, thus promoting recovery of multiple functions after stroke. Many studies have found that different interventions affect the prognosis of stroke patients differently, e.g., long-term acupuncture increases serum levels of brain-derived neurotrophic factor in stroke patients and also has better outcomes than controls in post-stroke neurological recovery and the development of post-stroke psychiatric disorders.

This study investigated the effects of different therapeutic measures on patients' functional recovery and neurotrophic factors by setting up a controlled and blinded trial design, which could not only provide clinical evidence for the effectiveness of relevant therapeutic measures, but also verify the clinical value of certain neurotrophic factors (e.g., predicting outcome, assessing condition, and preventing adverse events).

Conditions
Stroke
Being tested
acupuncture, computerized cognitive training system, aerobic exercise, tranditional cognitive training, Conventional treatment
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • acupunctureProcedure or surgery

    Manual acupuncture or electro-acupuncture by experienced acupuncturists for patients

  • computerized cognitive training systemBehavioural

    One-on-one cognitive training by an experienced cognitive therapist, combined with an existing computerized cognitive training system

  • aerobic exerciseBehavioural

    Patients are trained by experienced physical therapists with the help of elastic bands and physical therapy devices

  • tranditional cognitive trainingBehavioural

    One-on-one cognitive training with an experienced cognitive therapist, combined with traditional cognitive training methods (e.g., balls, cards, counting, daily conversation, etc.)

  • Conventional treatmentOther

    Treatment of underlying disease and stroke according to guidelines, as well as necessary care and rehabilitation

Study groups in NCT05479903
Study groupRoleWhat they receive
acupuncture stroke groupExperimentalNot described
Receives: Procedure: acupuncture; Other: Conventional treatment
sham acupuncture stroke groupSham comparatorNot described
Receives: Other: Conventional treatment
no acupuncture stroke groupPlacebo comparatorNot described
Receives: Other: Conventional treatment
acupuncture healthy groupPlacebo comparatorNot described
Receives: Procedure: acupuncture
computerized cognitive training groupExperimentalNot described
Receives: Behavioral: computerized cognitive training system; Other: Conventional treatment
tranditional cognitive training groupPlacebo comparatorNot described
Receives: Behavioral: aerobic exercise; Other: Conventional treatment
aerobics groupExperimentalNot described
Receives: Behavioral: tranditional cognitive training; Other: Conventional treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. modified rankin scale

    The mrs (modified rankin scale) is a scale used to assess the patient's ability to care for himself/herself, which is composed of independent walking ability, self-perceived symptoms, and ability to control bowel and urine.Assessment results range from 0-6 points,a higher score means a worse ending

    Measured: Change of the score of modified rankin scale from Baseline at 1 week after onset of disease

  2. modified rankin scale

    The mrs (modified rankin scale) is a scale used to assess the patient's ability to care for himself/herself, which is composed of independent walking ability, self-perceived symptoms, and ability to control bowel and urine.Assessment results range from 0-6 points,a higher score means a worse ending

    Measured: Change of the score of modified rankin scale from Baseline at 2 weeks after onset of disease

  3. modified rankin scale

    The mrs (modified rankin scale) is a scale used to assess the patient's ability to care for himself/herself, which is composed of independent walking ability, self-perceived symptoms, and ability to control bowel and urine.Assessment results range from 0-6 points,a higher score means a worse ending

    Measured: Change of the score of modified rankin scale from Baseline at 1 month after onset of disease

  4. modified rankin scale

    The mrs (modified rankin scale) is a scale used to assess the patient's ability to care for himself/herself, which is composed of independent walking ability, self-perceived symptoms, and ability to control bowel and urine.Assessment results range from 0-6 points,a higher score means a worse ending

    Measured: Change of the score of modified rankin scale from Baseline at 2 months after onset of disease

  5. modified rankin scale

    The mrs (modified rankin scale) is a scale used to assess the patient's ability to care for himself/herself, which is composed of independent walking ability, self-perceived symptoms, and ability to control bowel and urine.Assessment results range from 0-6 points,a higher score means a worse ending

    Measured: Change of the score of modified rankin scale from Baseline at 3 months after onset of disease

Secondary outcomes (1)
  1. Mini-mental State Examination

    The MMSE (Mini-mental State Examination) is a scale that assesses patients' cognition in terms of calculation, orientation, memory, and recall on a scale of 0-30, which is combined with the patient's level of education to yield results for different levels of cognitive impairment.

    Measured: Change of the score of modified rankin scale from Baseline at 1 week, 2 weeks, 1 month, 2 months, 3 months after onset of disease

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jul 2022
  2. Study start16 Nov 2021
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05479903
Sponsor's protocol ID
2021kelunshen110
Status last verified
Jul 2022
First submitted
21 Jul 2022
Last updated
29 Jul 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing acupuncture, computerized cognitive training system and aerobic exercise in people with Stroke, run by Chongqing Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lingcong Li, M.S. in Medicine (+8602385381636, molly2816@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

modified rankin scale (time frame: Change of the score of modified rankin scale from Baseline at 1 week after onset of disease). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in